For generations, the treatment of depression has been built around the removal of suffering — yet for the majority of those who live with it, the deepest wound is not pain but the extinction of joy. A clinical trial published in JAMA Network Open now offers evidence that a 15-session therapy called Positive Affect Treatment, developed by researchers at SMU and UCLA, can restore what conventional approaches have long left untouched: the brain's capacity to anticipate, receive, and learn from reward. In doing so, it challenges a foundational assumption of mental health care — that healing means
SciTechDaily
· May 12, 2026
· health
· 3 min read
High
Sourcing: Verified
New Therapy Targets Brain's Reward System to Restore Joy in Depression
Anhedonia increases suicide risk and prolongs severe depression in millions of patients, making this treatment advancement potentially life-saving.
◉
Health & Medicine
8098 related articles
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 100% match
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 99% match
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% match
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% match
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% match
Related Coverage
The Guardian · Aug 20
Hundreds of thousands await GCSE results as gender gap narrows to 10-year low
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Geopolitical Impact
🌎
New psychotherapy (PAT) targets depression's anhedonia symptom; primarily a healthcare/scientific development with no direct geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Bias & Framing
⚖
Article presents new depression therapy with optimistic framing and limited critical perspective on efficacy claims or potential limitations.
Bias Direction
center-left
Confidence
MED
Promotional framing emphasizing innovation and superiority; positions PAT as breakthrough solution while minimizing discussion of conventional treatments' merits or PAT's limitations.
most disabling symptoms
directly targeting
more effective treatment strategy
restore joy
largely overlooked
breakthrough approach
Critiques or limitations of PAT from independent researchers
Cost-effectiveness analysis compared to conventional treatments
Long-term follow-up data or relapse rates
Perspectives from practitioners of conventional depression therapies
Potential adverse effects or dropout rates
Comparative efficacy data with specific numbers/effect sizes
Accessibility and scalability concerns
Economic Lens
📈
New psychotherapy (PAT) targeting anhedonia shows promise for depression treatment, potentially expanding mental health care market and reducing long-term healthcare costs associated with treatment-resistant depression.
Market Signal
bullish
Confidence
MED
Healthcare/Mental Health Services
Pharmaceutical Industry
Medical Device/Digital Health
Insurance/Health Plans
Behavioral Health Technology
Patients with depression may access more effective treatments, potentially reducing disability, improving workforce productivity, and decreasing suicide-related costs. Could lower out-of-pocket expenses if PAT becomes standard covered therapy versus prolonged medication regimens.
Potential for insurance coverage expansion of psychotherapy-based treatments; regulatory review of PAT efficacy could influence mental health parity laws; may reduce pharmaceutical dependency, affecting drug pricing discussions; workplace mental health policies may evolve to incorporate reward-system-focused interventions.